Basit öğe kaydını göster

dc.contributor.authorPamuk, F.
dc.contributor.authorLutfioglu, M.
dc.contributor.authorAydogdu, A.
dc.contributor.authorKoyuncuoglu, C. Z.
dc.contributor.authorCifcibasi, E.
dc.contributor.authorBadur, O. S.
dc.date.accessioned2020-06-21T13:18:16Z
dc.date.available2020-06-21T13:18:16Z
dc.date.issued2017
dc.identifier.issn0022-3484
dc.identifier.issn1600-0765
dc.identifier.urihttps://doi.org/10.1111/jre.12457
dc.identifier.urihttps://hdl.handle.net/20.500.12712/12234
dc.descriptionLUTFIOGLU, MUGE/0000-0003-1499-5902en_US
dc.descriptionWOS: 000409224500008en_US
dc.descriptionPubMed: 28394081en_US
dc.description.abstractBackground and ObjectiveThis study aimed to investigate the effects of low-level laser therapy (LLLT) as an adjunct to scaling and root planing (SRP) on smoking and non-smoking patients with chronic periodontitis. Material and MethodsThe study was conducted using a split-mouth design with 30 patients with chronic periodontitis (15 smokers, 15 non-smokers) and 30 healthy individuals matched for age, sex and smoking status as controls. Groups were constituted as follows: Cp+SRP+Sham: non-smokers with chronic periodontitis treated with SRP; Cp+SRP+LLLT: non-smokers with chronic periodontitis treated with SRP+LLLT; SCp+SRP+Sham: smokers with chronic periodontitis treated with SRP; SCp+SRP+LLLT: smokers with chronic periodontitis treated with SRP+LLLT; C: control group comprised of periodontally healthy non-smokers; SC: control group comprised of periodontally healthy smokers. LLLT was first applied on the same day as SRP and again on days 2 and 7 after SRP treatment. Clinical parameters were recorded before non-surgical periodontal treatment (baseline) and on day 30. Gingival crevicular fluid samples were collected before periodontal treatment (baseline) and during follow-up visits on days 7, 14 and 30. Gingival crevicular fluid transforming growth factor (TGF)-1, tissue plasminogen activator (tPA) and plasminogen activator inhibitor 1 (PAI-1) levels were measured using enzyme-linked immunosorbent assay. ResultsAll clinical parameters showed significant reductions between baseline and day 30 following SRP treatment in both the LLLT and sham groups (P<.001). No significant differences were observed between the LLLT and sham groups of either the smokers or non-smokers (P>.05). Gingival crevicular fluid PAI-1 levels decreased significantly in the SCp+SRP+sham and SCp+SRP+LLLT groups (P<.05), and gingival crevicular fluid tPA levels decreased significantly in the Cp+SRP+sham, Cp+SRP+LLLT and SCp+SRP+LLLT groups (P<.05). Gingival crevicular fluid TGF-1 levels decreased significantly in all treatment groups (P<.05). Although no significant differences were found between the gingival crevicular fluid PAI-1, tPA and TGF-1 levels of the LLLT versus sham groups (P>.05) at any of the time points measured, both LLLT groups showed significant reductions in tPA/PAI-1 ratios over time. ConclusionWithin the limits of this study, LLLT may be understood to play a role in the modulation of periodontal tissue tPA and PAI-1 gingival crevicular fluid levels, particularly in smoking patients with chronic periodontitis, and may thus be recommended as an adjunct to non-surgical periodontal treatment.en_US
dc.description.sponsorshipDepartment of Scientific research projects, Istanbul aydin university [480.2-2401]en_US
dc.description.sponsorshipDepartment of Scientific research projects, Istanbul aydin university, Grant/Award Number: 480.2-2401en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1111/jre.12457en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectlow-level laser therapyen_US
dc.subjectperiodontitisen_US
dc.subjectplasminogen activator inhibitor 1en_US
dc.subjectsmokingen_US
dc.subjecttissue plasminogen activatoren_US
dc.subjecttransforming growth factoren_US
dc.titleThe effect of low-level laser therapy as an adjunct to non-surgical periodontal treatment on gingival crevicular fluid levels of transforming growth factor-beta 1, tissue plasminogen activator and plasminogen activator inhibitor 1 in smoking and non-smoking chronic periodontitis patients: A split-mouth, randomized control studyen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume52en_US
dc.identifier.issue5en_US
dc.identifier.startpage872en_US
dc.identifier.endpage882en_US
dc.relation.journalJournal of Periodontal Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster